Fuji Pharma (4554) · RiskRestated
Talent Acquisition and Development Risk
First written in FY2020. 2 of 3 entries say "Restated". Latest entry: FY2022.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Talent acquisition, development and retention, and labor compliance risksA theme 715 companies write about · 733 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2026: 27 of 103 companies on the "Worse" side.
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 733 threads.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「Since its founding, the company has fostered a corporate culture that values its people. Based on this culture, it is focusing on securing and developing personnel.」
Continues the personnel recruitment and development risk and the countermeasure based on a corporate culture that values its people. - FY2021RestatedAnnual report
「Since its founding, the company has fostered a corporate culture that values its people. Based on this culture, it is focusing on securing and developing personnel.」
Continues to identify personnel recruitment and development risks, and states its policy of focusing on recruitment and development based on a corporate culture that values its people. - FY2020First statedAnnual report
「On the other hand, if the company has difficulty securing personnel or personnel development does not progress smoothly, its operating results, financial position and other matters may be affected.」
Newly identifies the risk that difficulty securing or delays in developing personnel needed for business expansion may affect operating results and the financial position.